Abstract
Background: 5α steroid reductase deficiency (5αSRD) is an autosomal recessive enzymatic deficiency and mutations in the 5α steroid reductase type 2 gene (SRD5A2) result in male pseudohermaphrodism caused by decreased dihydrotestosterone (DHT) synthesis. Aim: To identify the specific mutations of the SRD5A2 gene in Cypriot patients with 5αSRD. Subjects and methods: Five unrelated patients with 46,XY karyotype were examined. Four of them were born with ambiguous genitalia and 1 patient, who was raised as girl, presented with primary amenorrhea. The hCG test was informative (elevated testosterone/DHT) of 5αSRD in 3 out of 4 subjects. Sequencing of the SRD5A2 gene was completed for all patients. Genomic DNA was also isolated from a total of 204 healthy unrelated Cypriot subjects. Screening for the IVS1-2A>G mutation was performed by using direct sequencing and restriction enzyme analysis. Results: The IVS1-2A>G was identified in homozygosity in 3 patients and in a compound heterozygote state in the other 2 patients, in combination with p.P181L and p.R171S in exon 3, respectively. The carrier frequency in the Cypriot population for the IVS1-2A>G mutation was estimated to be 0.98% or 2 in 204. Conclusions: The same IVS1-2A>G mutation in the SRD5A2 gene seems to characterize all Cypriot patients with 5αSRD diagnosed so far. Furthermore this relatively rare genetic defect, which has only been reported previously in a single case in the Eastern Mediterranean region, is very likely to be the result of a founder effect.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Blecher SR, Erickson RP. Genetics of sexual development: a new paradigm. Am J Med Genet A 2007, 143A: 3054–68.
Sultan C, Paris F, Terouanne B, et al. Disorders linked to insufficient androgen action in male children. Hum Reprod Update 2001, 7: 314–22.
Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993, 14: 577–93.
Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974, 186: 1213–5.
Sinnecker GH, Hiort O, Dibbelt L, et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 1996, 63: 223–30.
Mendonca BB, Inacio M, Costa EM, et al. Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 1996, 75: 64–76.
Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest 1992, 89: 293–300.
Lumbroso S, Lobaccaro JM, Georget V, et al. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance. J Clin Endocrinol Metab 1996, 81: 1984–8.
Boudon C, Lobaccaro JM, Lumbroso S, et al. A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 1995, 43: 183–8.
Ocal G, Adiyaman P, Berberoglu M, et al. Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J Pediatr Endocrinol Metab 2002, 15: 411–21.
Thigpen AE, Davis DL, Milatovich A, et al. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992, 90: 799–809.
Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zollner A, Struve D. Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1996, 81: 3415–8.
Ferraz LF, Mathias Baptista MT, Maciel-Guerra AT, Junior GG, Hackel C. New frameshift mutation in the 5alpha-reductase type 2 gene in a Brazilian patient with 5alpha-reductase deficiency. Am J Med Genet 1999, 87: 221–5.
Vilchis F, Canto P, Chavez B, Ulloa-Aguirre A, Méndez JP. Molecular analysis of the 5 alpha-steroid reductase type 2 gene in a family with deficiency of the enzyme. Am J Med Genet 1997, 69: 69–72.
Hiort O, Schutt SM, Bals-Pratsch M, Holterhus PM, Marschke C, Struve D. A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. Int J Androl 2002, 25: 55–8.
Hochberg Z, Chayen R, Reiss N, et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab 1996, 81: 2821–7.
Canto P, Vilchis F, Chavez B, et al. Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clin Endocrinol (Oxf) 1997, 46: 155–60.
Nordenskjöld A, Ivarsson SA. Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 1998, 83: 3236–8.
Sahakitrungruang T, Wacharasindhu S, Yeetong P, Snabboon T, Suphapeetiporn K, Shotelersuk V. Identification of mutations in the SRD5A2 gene in Thai patients with male pseudohermaphroditism. Fertil Steril 2008, 90: 2015.e11-15.
Nicoletti A, Baldazzi L, Balsamo A, et al. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf) 2005, 63: 375–80.
Vilchis F, Valdez E, Ramos L, Garcia R, Gomez R, Chavez B. Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia. J Hum Genet 2008, 53: 401–6.
Adiyaman PB, Ocal G, Cetinkaya E, et al. 5 alpha steroid reductase deficiency in Turkey. Pediatr Endocrinol Rev 2006, 3 (Suppl 3): 462–9.
Baldinotti F, Majore S, Fogli A, et al. Molecular characterization of 6 unrelated Italian patients with 5alpha-reductase type 2 deficiency. J Androl 2008, 29: 20–8.
Russell DW, Berman DM, Bryant JT, et al. The molecular genetics of steroid 5 alpha-reductases. Recent Prog Horm Res 1994, 49: 275–84.
Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 1991, 354: 159–61.
Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH, Yoo HW. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development. J Pediatr Endocrinol Metab 2008, 21: 545–53.
Yiallouros PK, Neocleous V, Zeniou M, et al. Cystic fibrosis mutational spectrum and genotypic/phenotypic features in Greek-Cypriots, with emphasis on dehydration as presenting symptom. Clin Genet 2007, 71: 290–2.
Dean G, Chamberlain S, Middleton L. Friedreich’s ataxia in Kathikas-Arodhes, Cyprus. Lancet 1988, 1: 587.
Belguith H, Hajji S, Salem N, et al. Analysis of GJB2 mutation: evidence for a Mediterranean ancestor for the 35delG mutation. Clin Genet 2005, 68: 188–9.
Neocleous V, Aspris A, Shahpenterian V, et al. High frequency of 35delG GJB2 mutation and absence of del(GJB6-D13S1 830) in Greek Cypriot patients with nonsyndromic hearing loss. Genet Test 2006, 10: 285–9.
Skordis N, Patsalis PC, Bacopoulou I, Sismani C, Sultan C, Lumbroso S. 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect. J Pediatr Endocrinol Metab 2005, 18: 241–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skordis, N., Neocleous, V., Kyriakou, A. et al. The IVS1- 2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency. J Endocrinol Invest 33, 810–814 (2010). https://doi.org/10.1007/BF03350347
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350347